These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 15212021)
1. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research. Caulfield T Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021 [No Abstract] [Full Text] [Related]
2. Regulating scientific research: intellectual property rights and the norms of science. Rai AK Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815 [No Abstract] [Full Text] [Related]
3. The scope of utility in the twenty-first century: new guidance for gene-related patents. Summers TM Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071 [No Abstract] [Full Text] [Related]
4. Adequate protection for the autonomous research subject? The disclosure of sources of funding and commercialisation in genetic research trials. Cote A Manit Law J; 2002; 28(3):347-58. PubMed ID: 15162817 [No Abstract] [Full Text] [Related]
5. The Human Genome Project: a public good. Hudson K Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360 [No Abstract] [Full Text] [Related]
6. Wrong map: why public science can't really be public. Mukherjee S New Repub; 2000 May; 222(19):14-5. PubMed ID: 12465651 [No Abstract] [Full Text] [Related]
7. [Commercialization of genetic research and its impact on the communication of results]. Cardinal G Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367 [TBL] [Abstract][Full Text] [Related]
8. The times they are a-changin'. Patrinos A; Drell D Nature; 2002 Jun; 417(6889):589-90. PubMed ID: 12050635 [No Abstract] [Full Text] [Related]
9. In pursuit of patents: 21st century challenges. Blatt RJ J Biolaw Bus; 1998; 1(4):4-7. PubMed ID: 11657745 [No Abstract] [Full Text] [Related]
10. Homo economicus: commercialization of body tissue in the age of biotechnology. Nelkin D; Andrews L Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768 [TBL] [Abstract][Full Text] [Related]
11. Genetic patents: gatekeeper to the promised cures. Westin LP Thomas Jefferson Law Rev; 2002; 25(1):271-99. PubMed ID: 15164741 [No Abstract] [Full Text] [Related]
12. Divided loyalties: trust in science is being eroded. How can we restore it? New Sci; 2005 Feb 26-Mar 4; 185(2488):3. PubMed ID: 15839009 [No Abstract] [Full Text] [Related]
13. Genomic capital: public cultures and market logics of corporate biotechnology. Rajan KS Sci Cult (Lond); 2003 Mar; 12(1):87-121. PubMed ID: 15971369 [No Abstract] [Full Text] [Related]
14. For sale: The Framingham Heart Study. Ready T Nat Med; 2000 Jul; 6(7):721. PubMed ID: 10888896 [No Abstract] [Full Text] [Related]
15. Who owns the genome? Angrist M; Cook-Deegan RM New Atlantis; 2006; 11():87-96. PubMed ID: 16789312 [No Abstract] [Full Text] [Related]
16. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience. Caulfield T; Ogbogu U Account Res; 2008; 15(4):303-20. PubMed ID: 18972268 [TBL] [Abstract][Full Text] [Related]
17. Contrary to first impression, genes are patentable: should there be limitations? Pitcher AS J Health Care Law Policy; 2003; 6(2):284-303. PubMed ID: 15017959 [No Abstract] [Full Text] [Related]
18. Progress or peril? The ethical questions of human DNA mapping. Belsie L Christ Sci Monitor; 1999 Aug; ():15, 18. PubMed ID: 11648132 [No Abstract] [Full Text] [Related]
19. Governing population genomics: law, bioethics, and biopolitics in three case studies. Winickoff DE Jurimetrics; 2003; 43(2):187-228. PubMed ID: 15156881 [TBL] [Abstract][Full Text] [Related]
20. Actor-network theory: a tool to support ethical analysis of commercial genetic testing. Williams-Jones B; Graham JE New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]